Home > Qtrly Results > ORCHID PHARMA

ORCHID PHARMA
Quarterly Results Analysis [Dec2025]

AD     Remove this Ad

ORCHID PHARMA Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹207 Cr ₹194 Cr ₹173 Cr ₹237 Cr ₹217 Cr ₹223 Cr ₹244 Cr ₹217 Cr
Expenses ₹206 Cr ₹195 Cr ₹159 Cr ₹209 Cr ₹191 Cr ₹192 Cr ₹212 Cr ₹188 Cr
Operating Income ₹2 Cr ₹-1 Cr ₹14 Cr ₹28 Cr ₹26 Cr ₹30 Cr ₹32 Cr ₹29 Cr
Other Income ₹6 Cr ₹11 Cr ₹11 Cr ₹4 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹13 Cr
Interest ₹3 Cr ₹4 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Depreciation ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹8 Cr ₹8 Cr
Profit Before Tax ₹-12 Cr ₹-3 Cr ₹14 Cr ₹19 Cr ₹22 Cr ₹26 Cr ₹28 Cr ₹30 Cr
Profit After Tax ₹-12 Cr ₹-3 Cr ₹14 Cr ₹19 Cr ₹22 Cr ₹26 Cr ₹28 Cr ₹34 Cr
EPS ₹-2.49 ₹-1.13 ₹2.94 ₹4.40 ₹4.10 ₹5.37 ₹5.79 ₹6.50
Industry Peers & Returns1W1M1Y
ORCHID PHARMA -3.7% -6.6% -46.6%
SUN PHARMACEUTICAL INDUSTRIES 0.4% 2.6% NA
DIVIS LABORATORIES -4.5% 0.7% 3.4%
CIPLA -0.5% -3.4% -6.7%
TORRENT PHARMACEUTICALS 5% 4.1% 37.2%
DR REDDYS LABORATORIES 1.2% 10.2% 4.8%
MANKIND PHARMA -1.1% -2.6% -15.1%
ZYDUS LIFESCIENCES 1% 2.9% -3.4%
LUPIN 1.8% 3.2% 7.5%

ORCHID PHARMA Quarterly Revenues

Revenues
Q-o-Q

7.10 %

Y-o-Y

-4.64 %

Quarters Revenues % Change
Dec2025 ₹207 Cr
7.10
Sep2025 ₹194 Cr
11.91
Jun2025 ₹173 Cr
-27.18
Mar2025 ₹237 Cr
9.26
Dec2024 ₹217 Cr
-2.41
Sep2024 ₹223 Cr
-8.88
Jun2024 ₹244 Cr
12.58
Mar2024 ₹217 Cr -

ORCHID PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

Positive

Y-o-Y

-94.07 %

Quarters Operating Profit % Change
Dec2025 ₹2 Cr
Positive
Sep2025 ₹-1 Cr
Negative
Jun2025 ₹14 Cr
-49.35
Mar2025 ₹28 Cr
6.15
Dec2024 ₹26 Cr
-13.10
Sep2024 ₹30 Cr
-6.63
Jun2024 ₹32 Cr
12.36
Mar2024 ₹29 Cr -
Operating Margins
Q-o-Q

Positive

Y-o-Y

-93.82 %

Quarters Operating Margin% % Change
Dec2025 0.75%
Positive
Sep2025 -0.76%
Negative
Jun2025 8.2%
-30.39
Mar2025 11.78%
-2.89
Dec2024 12.13%
-10.94
Sep2024 13.62%
2.48
Jun2024 13.29%
-0.23
Mar2024 13.32% -

ORCHID PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Dec2025 ₹-12 Cr
Negative
Sep2025 ₹-3 Cr
Negative
Jun2025 ₹14 Cr
-28.35
Mar2025 ₹19 Cr
-14.77
Dec2024 ₹22 Cr
-13.32
Sep2024 ₹26 Cr
-8.40
Jun2024 ₹28 Cr
-15.60
Mar2024 ₹34 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Dec2025 -5.86 %
Negative
Sep2025 -1.72 %
Negative
Jun2025 7.93 %
-1.61
Mar2025 8.06 %
-21.97
Dec2024 10.33 %
-11.18
Sep2024 11.63 %
0.52
Jun2024 11.57 %
-25.02
Mar2024 15.43 % -

ORCHID PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Dec2025 ₹-2.49
Negative
Sep2025 ₹-1.13
Negative
Jun2025 ₹2.94
-33.18
Mar2025 ₹4.4
7.32
Dec2024 ₹4.1
-23.65
Sep2024 ₹5.37
-7.25
Jun2024 ₹5.79
-10.92
Mar2024 ₹6.5 -

You may also like the below Video Courses